Galera Therapeutics Statistics
Total Valuation
GRTX has a market cap or net worth of 1.79 million. The enterprise value is 150.20 million.
| Market Cap | 1.79M |
| Enterprise Value | 150.20M |
Important Dates
The last earnings date was Friday, November 7, 2025.
| Earnings Date | Nov 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
GRTX has 75.46 million shares outstanding. The number of shares has increased by 46.90% in one year.
| Current Share Class | 75.46M |
| Shares Outstanding | 75.46M |
| Shares Change (YoY) | +46.90% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 29.27% |
| Owned by Institutions (%) | 6.53% |
| Float | 44.12M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -0.01 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -16.72 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.20
| Current Ratio | 8.20 |
| Quick Ratio | 7.48 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -55.36% |
| Return on Invested Capital (ROIC) | -62.11% |
| Return on Capital Employed (ROCE) | -139.80% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -3.00M |
| Employee Count | 3 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -52.00% in the last 52 weeks. The beta is 1.89, so GRTX's price volatility has been higher than the market average.
| Beta (5Y) | 1.89 |
| 52-Week Price Change | -52.00% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.03 |
| Relative Strength Index (RSI) | 52.83 |
| Average Volume (20 Days) | 295,098 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -6.16M |
| Pretax Income | -8.99M |
| Net Income | -8.99M |
| EBITDA | -6.14M |
| EBIT | -6.16M |
| Earnings Per Share (EPS) | -0.10 |
Balance Sheet
The company has 4.47 million in cash and 151.05 million in debt, giving a net cash position of -146.58 million or -1.94 per share.
| Cash & Cash Equivalents | 4.47M |
| Total Debt | 151.05M |
| Net Cash | -146.58M |
| Net Cash Per Share | -1.94 |
| Equity (Book Value) | -146.65M |
| Book Value Per Share | -1.98 |
| Working Capital | 4.30M |
Cash Flow
| Operating Cash Flow | -6.79M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
GRTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -46.90% |
| Shareholder Yield | -46.90% |
| Earnings Yield | -502.44% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |